iBio, Inc.IBIONYSE
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-10.79%
↑ 95% above average
Average (39q)
-202.25%
Historical baseline
Range
High:101.51%
Low:-7806.03%
CAGR
-2.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -10.79% |
| Q2 2025 | -6.21% |
| Q1 2025 | -11.39% |
| Q4 2024 | -9.40% |
| Q3 2024 | 48.71% |
| Q2 2024 | -145.21% |
| Q1 2024 | 61.37% |
| Q4 2023 | -42.90% |
| Q3 2023 | 4.76% |
| Q2 2023 | 17.29% |
| Q1 2023 | 78.26% |
| Q4 2022 | -85.07% |
| Q3 2022 | -6.31% |
| Q2 2022 | -37.64% |
| Q1 2022 | -3.94% |
| Q4 2021 | -33.35% |
| Q3 2021 | -7806.03% |
| Q2 2021 | 101.51% |
| Q1 2021 | 5.76% |
| Q4 2020 | -7.91% |
| Q3 2020 | -112.92% |
| Q2 2020 | 24.34% |
| Q1 2020 | -24.30% |
| Q4 2019 | 15.71% |
| Q3 2019 | 0.89% |
| Q2 2019 | -6.63% |
| Q1 2019 | 5.50% |
| Q4 2018 | -1.61% |
| Q3 2018 | 0.45% |
| Q2 2018 | -11.51% |
| Q1 2018 | -1.62% |
| Q4 2017 | -1.91% |
| Q3 2017 | 11.62% |
| Q2 2017 | -10.63% |
| Q1 2017 | -21.18% |
| Q4 2016 | -5.49% |
| Q3 2016 | -14.34% |
| Q2 2016 | 11.82% |
| Q1 2016 | -35.17% |
| Q4 2015 | -24.43% |